Traffic
11.66K
1,982,865
1,055,457
1,369
00:19
1.67
46.07%
33.7%
Traffic sources
- Search33.7%
- Direct30.3%
- Display ads8.8%
- Referrals8.0%
- Social7.0%
- Paid search4.2%
- Email3.4%
- Other2.5%
- Generative AI2.1%
Regions
- United States35.7%
- India25.7%
- Vietnam23.3%
- Canada10.7%
- Japan2.6%
Related boards: Most visited websites in the United States · Top pharmacy websites by traffic · Fastest growing pharmacy websites
See how newdrugapprovals.org compares with the most visited websites in the world, the fastest growing websites, top websites by AI referrals and sites gaining organic search traffic.
Search visibility
Keyword samples
- why is rebamipide not fda approved21022096%
- tagoor laboratories tegoprazan process120—
- durlobactam total synthesis11036031%
- palovarotene total synthesis11036031%
- vimseltinib synthesis11012092%
Keyword rankings
Keyword rankings
See the keywords newdrugapprovals.org ranks for on Google, the pages that bring it traffic, and the competitors fighting it for search traffic.
Live examples: chatgpt.com · github.com · plausible.io
Unlock ProSimilar sites
Website reports in the same category, with nearby monthly visits.
What's in this report
The report starts with a whole-site monthly visit estimate. Search visibility and public site facts follow when they exist.
- Website traffic is a modeled whole-site estimate, with a source, observation period and confidence.
- Search visibility is ranking keywords and search traffic, listed separately from whole-site visits.
- Missing or partial values stay marked in the report.
Cite or embed
newdrugapprovals.org had about 11.66K visits in September 2026, up 20.40% from August; the top source is search. Source: Vaneform estimates, https://vaneform.com/e/newdrugapprovals-org (updated 2026-09-01).
Show this report's monthly visits on your site or README. Updates with each data month.
<a href="https://vaneform.com/e/newdrugapprovals-org" rel="nofollow"><img src="https://vaneform.com/api/badge/newdrugapprovals-org" alt="newdrugapprovals.org monthly visits · Vaneform" height="20"></a>